Drug Discovery & Molecular Design - software & AI news

Daily news on software, AI, and companies shaping drug discovery & molecular design.

Showing 377 results
A flat illustration of a patent document with a checkmark, representing approval in drug discovery.

Apr 28, 2026

Patent Analysis Is Increasingly Shaping AI-driven Target And Drug Candidate Selection - Healthcare - Isle of Sark

The integration of artificial intelligence (AI) in drug discovery is revolutionizing the identification of therapeutic targets and candidates, yet it introduces complexities in resource allocation for these inventions.Recent insights from a review by Pun et al. in *Nature Reviews Drug Discovery* highlight how AI enhances target identification through innovative techniques like multi-omics integration and knowledge graphs. This expansion necessitates a new framework that incorporates not only tra
A minimalist illustration of a pill symbolizing drug discovery in biotech.

Apr 27, 2026

Korean Biotech Firms Forge 'AI Alliances' to Discover Next-Generation Drugs

Korean biotech companies are increasingly forming alliances focused on AI-driven drug discovery, aiming to enhance the efficiency and success rates of developing new therapeutics.One notable partnership is between HK inno.N and Atommerce, which was announced recently. This collaboration targets the development of innovative treatments for obesity, specifically seeking to identify new drug candidates that do not rely on the existing GLP-1 (incretin) therapies. By leveraging Atommerce's advanced A
Petri dish with cultured cells in a dimly lit lab

Apr 27, 2026

German drugmaker launches AI research centre in London

Boehringer Ingelheim is set to enhance its research capabilities by establishing a new AI and machine learning centre in London, aimed at revolutionizing drug discovery.The facility, located in the Knowledge Quarter at King’s Cross, will concentrate on the integration of AI into human biology, facilitating the development of targeted therapies. This initiative is part of a broader strategy to utilize AI and machine learning to expedite the identification and modeling of biological processes crit
Flat design of a small molecule and protein silhouette

Apr 27, 2026

Fathom Therapeutics, Formerly Atommap, Raises $47 Million in Oversubscribed Series A Financing to Translate Physics and AI-Enabled Small Molecule Design into Next-Generation Medicines

Fathom Therapeutics, previously known as Atommap, has successfully raised $47 million in an oversubscribed Series A funding round, aimed at enhancing its innovative drug design capabilities through quantum chemistry and AI technologies.Led by Sutter Hill Ventures, this financing round also saw participation from several other prominent investors. Fathom's proprietary platform, Microcosmos, leverages advanced algorithms to simulate protein dynamics at an unprecedented scale, facilitating the desi
Minimalist illustration of a small molecule in pill form on a dark background.

Apr 27, 2026

HK inno.N, Atomatrix partner on AI-based obesity drug development

HK inno.N has entered a partnership with Atomatrix to leverage AI in the development of innovative obesity treatments.This collaboration aims to explore small-molecule candidates that utilize new mechanisms of action, moving away from the prevalent incretin-based therapies in the obesity market. HK inno.N will handle drug synthesis and biological evaluation, focusing on the efficacy and safety of the compounds, while Atomatrix will utilize its proprietary CANDDIE platform for molecule design and